VIRICA BIOTECH
Virica Biotech is a biotechnology company that addresses the unmet needs in production and development to positively change human health. Its Viral Sensitizer technology consists of a library of over one hundred small molecules that can safely overcome the natural immunological defenses in the human and animal body that suppress effective viral medicines.
VIRICA BIOTECH
Industry:
Biotechnology Health Care Medical
Founded:
2018-01-01
Address:
Ottawa, Ontario, Canada
Country:
Canada
Website Url:
http://www.viricabiotech.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.18 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics LetsEncrypt SSL By Default Global Site Tag
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Current Advisors List
Current Employees Featured
Founder
Investors List
FedDev
FedDev investment in Grant - Virica Biotech
National Institute for Innovation in Manufacturing Biopharmaceuticals
National Institute for Innovation in Manufacturing Biopharmaceuticals investment in Grant - Virica Biotech
Capital Angel Network
Capital Angel Network investment in Venture Round - Virica Biotech
Ontario Together Fund
Ontario Together Fund investment in Grant - Virica Biotech
Dynamk Capital
Dynamk Capital investment in Series A - Virica Biotech
Invest Ottawa
Invest Ottawa investment in Non Equity Assistance - Virica Biotech
Key Employee Changes
| Date | New article |
|---|---|
| 2023-01-05 | Virica Biotech Announces Industry Veteran, Beth Thompson-Webb, as Chief Commercial Officer |
Official Site Inspections
http://www.viricabiotech.com
- Host name: rssd5382.webaccountserver.com
- IP address: 192.138.189.115
- Location: Cary United States
- Latitude: 35.7965
- Longitude: -78.7981
- Metro Code: 560
- Timezone: America/New_York
- Postal: 27513
More informations about "Virica Biotech"
Virica Biotech - Viral Sensitizers (VSE)
Virica has developed a library of Viral Sensitizers (VSE™) that help to reduce these antiviral defenses during production. VSEs alter cellular signaling and dampen antiviral defenses. This …See details»
Government of Ontario Invests in Virica Biotech to …
Ottawa, Canada – April 21, 2023 – Virica Biotech Inc. (“Virica”), a leading supplier and developer of novel viral enhancers, announced today it is expanding its bioprocessing facilities and increasing its capacity to scale up the …See details»
Virica Biotech - Virica Biotech Announces Collaboration with the ...
Ottawa, Canada – May 2, 2022 – Virica Biotech Inc. (“Virica”), a leading developer of solutions for scaling of viral medicines, today announced it has received $400,000 from Innovation, Science …See details»
Virica Biotech - LinkedIn
Virica Biotech is at the forefront, empowering CGT and vaccine manufacturers to drive up productivity and drive down COGS. Our versatile Viral Sensitizers (VSEᵀᴹ) are small molecule …See details»
Virica Biotech | Ontario Bioscience Innovation Organization Job …
Virica Biotech is a biotechnology company that addresses the unmet needs in production and development to positively change human health.See details»
Virica Biotech - Crunchbase Company Profile & Funding
Virica Biotech is a biotechnology company that addresses the unmet needs in production and development to positively change human health. Virica Biotech received funding from the federal government, which will enable the company …See details»
Virica Biotech Announces Collaboration with the Government of …
May 2, 2022 · Virica is deploying its custom VSE™ formulation, in collaboration with the NRC, to design a more robust AAV vector manufacturing process. The VSE™ formulation is tailor …See details»
Government of Ontario Invests in Virica Biotech | Business Wire
Apr 22, 2023 · OTTAWA, Canada-- ( BUSINESS WIRE )-- Virica Biotech Inc. (“Virica”), a leading supplier and developer of novel viral enhancers, announced today it is expanding its …See details»
Ottawa Founders: Virica Biotech makes gene therapies, viral …
Jan 18, 2024 · Ella Korets-Smith is having a hectic morning, busily working on a big grant application for Virica Biotech, an Ottawa-based medical sciences startup she co-founded that …See details»
Our Story - Virica Biotech
Our purpose is to realize the promise of viral medicines, thereby extending the horizons of human healthcare. We pioneered a new product category of Viral Sensitizers (VSE™) that removes …See details»
Virica Company Profile 2024: Valuation, Funding & Investors
Developer of a viral sensitizer technology designed to produce viral vector therapeutic products. The company's technology consists of a library of small molecules of viral sensitizers which …See details»
Virica Biotech Raises Series A Financing and Expands Operations …
Oct 4, 2021 · OTTAWA, Ontario-- ( BUSINESS WIRE )--Virica Biotech Inc., a leading life science developer of solutions for scaling of viral medicines, announced today the first closing of its …See details»
Virica Expands Bioprocessing Capabilities with Carleton University ...
Jan 16, 2024 · Virica Biotech Inc. (“Virica”), a leading developer of cell enhancers for scaling of viral vector as well as cell and gene therapy manufacturing will expand its bioprocessing …See details»
Virica Biotech - Overview, News & Similar companies - ZoomInfo
Jan 5, 2024 · Virica Biotech contact info: Phone number: (613) 737-8899 Website: www.viricabiotech.com What does Virica Biotech do? Founded in 2018 and headquartered in …See details»
Virica Biotech Announces Collaboration with the Government of …
Canada (ISED) through the Innovative Solutions Canada (ISC) program. This funding supports Virica’s collaboration with the National Research Council of Canada’s (NRC) Cell and Gene …See details»
Virica Biotech Announces R&D Partnership With Oxford Biomedica …
Jan 24, 2022 · Virica Biotech signs R&D partnership with Oxford Biomedica to improve the manufacturing yields of lentiviral vector gene therapies using VSEs™.See details»
Virica Kicks Off 2024 with a New Head of Global Sales and a Full ...
OTTAWA, Ontario, January 05, 2024--Virica Biotech Inc. ("Virica"), a leading developer of cell enhancers for scaling of viral vectors, as well as cell and gene therapies, announced today the...See details»
Technology for Drug Developers and Manufacturers - Virica Biotech
Our proprietary and pioneering Viral Sensitizers (VSE™) unlock your potential to increase yield and effectiveness while reducing cost. Virica is the first company to develop and …See details»
Virica Biotech - BIO Investor Forum | BIO
VSEs are small molecules that reduce the anti-viral responses of cells, thereby improving product yields and therapeutic efficacy for gene therapies, vaccines and oncolytic viruses. Virica's …See details»
Virica Kicks Off 2024 with a New Head of Global Sales and a Full ...
Jan 5, 2024 · OTTAWA, Ontario-- ( BUSINESS WIRE )--Virica Biotech Inc. (“Virica”), a leading developer of cell enhancers for scaling of viral vectors, as well as cell and gene therapies, …See details»